LIONS BAY depends - like many others - on SARS-CoV-2 research
;-))
Lions Bay target preparing for COVID vaccine study
2020-05-14 12:42 ET - News Release
Mr. Jeremy Poirier reports
LIONS BAY MINING ANNOUNCES UPDATE ON ACQUISITION TARGET BIOVAXYS INITIATING A SARS-COV-2 VACCINE STUDY AND DEFINITIVE AGREEMENT
Lions Bay Mining Corp. has been informed that BioVaxys LLC is in the process of preparing to launch a preclinical study of its proprietary vaccine for SARS-CoV-2, the virus that causes COVID-19. Lions Bay recently announced entering into a non-binding letter of intent dated April 17, 2020, to acquire BioVaxys, a private Delaware corporation that is developing viral and oncology vaccine platforms for SARS-CoV-2 and various cancers.